Literature DB >> 15450070

Buformin-induced lactic acidosis--a symptom of modern healthcare malady.

Mahesh Krishnamurthy, Julieanna Jad Sahouria, Ravi Desai, Juanito Caguiat.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15450070     DOI： 10.1111/j.1532-5415.2004.52479_7.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN： 0002-8614            Impact factor:   5.562


× No keyword cloud information.
  4 in total

1.  Buformin exhibits anti-proliferative and anti-invasive effects in endometrial cancer cells.

Authors:  Joshua Kilgore; Amanda L Jackson; Leslie H Clark; Hui Guo; Lu Zhang; Hannah M Jones; Timothy P Gilliam; Paola A Gehrig; Chunxiao Zhou; Victoria L Bae-Jump
Journal:  Am J Transl Res       Date:  2016-06-15       Impact factor: 4.060

2.  Buformin suppresses proliferation and invasion via AMPK/S6 pathway in cervical cancer and synergizes with paclitaxel.

Authors:  Jing Li; Ling Chen; Qiuli Liu; Mei Tang; Yuan Wang; Jinjin Yu
Journal:  Cancer Biol Ther       Date:  2018-02-27       Impact factor: 4.742

3.  Buformin increases radiosensitivity in cervical cancer cells via cell-cycle arrest and delayed DNA-damage repair.

Authors:  Ling Chen; Ting Zhang; Qiuli Liu; Mei Tang; Yu'e Yang; Yuan Wang; Haifeng Qiu; Jinjin Yu
Journal:  Exp Biol Med (Maywood)       Date:  2018-10

4.  Buformin suppresses osteosarcoma via targeting AMPK signaling pathway.

Authors:  Yan Ding; Shiqiao Lv; Guangrun Li; Jinpeng Cui; Yunzhen Chen
Journal:  Open Life Sci       Date:  2020-06-30       Impact factor: 0.938
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.